These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP; Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296 [TBL] [Abstract][Full Text] [Related]
4. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants. Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines. Ciruela P; Martínez A; Izquierdo C; Hernández S; Broner S; Muñoz-Almagro C; Domínguez À; Hum Vaccin Immunother; 2013 Mar; 9(3):681-91. PubMed ID: 23303166 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [TBL] [Abstract][Full Text] [Related]
7. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy). Trucchi C; Zoppi G J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174 [TBL] [Abstract][Full Text] [Related]
8. The pneumococcal protein conjugate vaccines. Peters TR; Edwards KM J Pediatr; 2000 Sep; 137(3):416-20. PubMed ID: 10969270 [No Abstract] [Full Text] [Related]
9. Haemophilus, meningococcus and pneumococcus: comparative epidemiologic patterns of disease. Hausdorff W Int J Clin Pract Suppl; 2001 Feb; (118):2-4. PubMed ID: 11715360 [No Abstract] [Full Text] [Related]
10. Disease transmission: routes, contributing factors and herd immunity. O'Brien K Int J Clin Pract Suppl; 2001 Feb; (118):5-7. PubMed ID: 11715363 [No Abstract] [Full Text] [Related]
11. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [TBL] [Abstract][Full Text] [Related]
12. Pneumococcal conjugate vaccines in Asia and the Pacific. Singapore, 9-11 October 2000. Report of an Asia Pacific Board Advisory Meeting. Vaccine; 2001 Sep; 19(32):4579-87. PubMed ID: 11729814 [No Abstract] [Full Text] [Related]
13. Evolution of conjugate vaccines. Mäkelä PH; Käyhty H Expert Rev Vaccines; 2002 Oct; 1(3):399-410. PubMed ID: 12901578 [TBL] [Abstract][Full Text] [Related]
14. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of CRM₁₉₇ conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants. Mallet E; Brachet E; Fernsten P; Laudat F; Razmpour A; Gruber WC; Vaccine; 2011 Aug; 29(34):5812-9. PubMed ID: 21296118 [TBL] [Abstract][Full Text] [Related]
16. Experience of vaccination against invasive bacterial diseases in Veneto region (north east Italy). Russo F; Pozza F; Napoletano G; Zanella F; Baldovin T; Lazzari R; Cocchio S; Baldo V J Prev Med Hyg; 2012 Jun; 53(2):113-5. PubMed ID: 23240172 [TBL] [Abstract][Full Text] [Related]
17. [Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal]. De Queirós L; Castro L; Ferreira MC; Gonçalves G Acta Med Port; 2004; 17(1):49-53. PubMed ID: 15636727 [TBL] [Abstract][Full Text] [Related]
18. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents. Zoppi G; Trucchi C J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175 [TBL] [Abstract][Full Text] [Related]
19. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545 [TBL] [Abstract][Full Text] [Related]
20. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy. Blanchard-Rohner G; Pollard AJ Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]